Global Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market - Forecast till 2023

Information By Treatment (Intravenous Immunoglobulin, Corticosteroids, Plasmapheresis (Plasma Exchange), Physiotherapy, Others), Diagnosis (Electrodiagnostic Testing, Nerve Conduction, EMG, Spinal Fluid Analysis, Others), By Route of Administration (Intravenous, Oral, Others), By End User (Hospitals, Specialty Neurological Clinics, Research & Academic Laboratories, Others) and Top Regions

Published	Pages	Publisher	Report code
Feb 2019	135	Market Research Future	ASDR-483158

Published: Feb 2019 - Pages : 135 - Publisher : Market Research Future - Report code : ASDR-483158

Kedrion S.p.A
Octapharma
Shire
Mitsubishi Tanabe Pharma Corporation
Momenta Pharmaceuticals
Grifols
Baxter